A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

GLP-1 receptor agonists may increase the risk of several autoimmune diseases in adults with type 2 diabetes, according to ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

Compounded vs non-compounded GLP-1 RA drug products are associated with an increased risk for adverse events such as nausea and diarrhea.

GLP-1 medicines are licensed for Type 2 diabetes and weight management, and include the branded products Ozempic, Mounjaro ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

People undergoing metabolic and bariatric surgery are less likely to develop psychiatric disorders than those treated with GLP-1 RAs.

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...